:

69.
  • ,

    37 53.62%
  • 23 33.33%
  • ,

    9 13.04%
4 20 1234567891011121314 ...
31 40 193

: (Salofalk 1000mg gastro-resistant prolonged release granules)

  1. #31

    30.09.2010
    28

    Exclamation - Apriso,

    Apriso ( ).
    .: http://www.medicalnewstoday.com/articles/152580.php
    "...Salix acquired rights to market APRISO in the U.S. from Dr. Falk Pharma GmbH of Freiburg, Germany. Mesalamine granules have been approved in Germany since 2001 for the treatment of symptoms related to inflammatory bowel disease. In addition, consistent with the FDA-approved labeling, once-daily dosing of mesalamine granules is currently approved via the mutual recognition procedure in Austria, Belgium, Denmark, Finland, Greece, Ireland, Luxemburg, Netherlands, Norway, Portugal, Sweden, Spain and the UK..."

    . .

    ( ):
    1) , , , , , Apriso - 500 1 ;
    2) , . , ( 8 - 86% ): http://gut.bmj.com/content/58/2/233.full.pdf
    3) 3 ( 80%), - 1,5 (79% 6 : http://www.ncbi.nlm.nih.gov/pubmed/20937044)
    4) , (, ), .

    !
       

  2. #32

    23.09.2010
    ,
    47
    26,934
    12

    , . , .
       

  3. #33

    30.09.2010
    28

    Exclamation , 5-!

    , . , .
    ! , ?!

    . , , - 5- - ( )!

    , "" : http://www.aprisorx.com/for-healthca...als/index.aspx

    , !
    nikolas_101; 27.02.2011 03:17.
       

  4. #34

    23.09.2010
    ,
    47
    26,934
    12

    . , -. .
       

  5. #35

    30.09.2010
    28

    ? , ? 5-? ? , . , , , ...
    ( ) - . . , .
    nikolas_101; 01.03.2011 14:24.
       

  6. #36

    23.09.2010
    ,
    47
    26,934
    12

    , ( ) !
    !
    !
    , !

    . .
       

  7. #37

    30.09.2010
    28

    . ( ). - : , . , .
    , , , - - . , , , . , , . 4 , 2009 , , (), (78% 55% 32% 15%). . . 6 : http://www.gastroenterology.ru/S5r_5-7_2010_e.pdf
    , !
       

  8. #38

    23.09.2010
    ,
    47
    26,934
    12

    . . , . ! 8 10% 3 %!

    . 0,25. . . . . . .
       

  9. #39

    30.09.2010
    28

    , " ". - - . !
    (3-3,5 ) ( , ). - (3 ) ( ).
       

  10. #40

    23.09.2010
    ,
    47
    26,934
    12

    - . . . ? ? ? . 2- .
       

,

: 1 (: 0 , : 1)

  •